AM Southcott, KP Jones, D Li, S Majumdar, AD Cambrey, P Pantelidis, CM Black, GJ Laurent, BH Davies and PK Jeffery
Interstitial Lung Disease Unit, Royal Brompton National Heart and Lung Hospital, London, England.

Fibrosing alveolitis may occur alone (CFA) or in association with systemic sclerosis (FASSc). FASSc was recently shown to have a prognostic advantage over CFA. Because interleukin-8 (IL-8) is likely to be a major determinant of neutrophil alveolitis, we evaluated IL-8 expression in patients with CFA and FASSc and compared it with that in normal individuals and sarcoidosis and systemic sclerosis patients without pulmonary involvement (SSc no FA). IL-8 protein in bronchoalveolar lavage fluid (BALF) was assessed by immunoassay, and IL- 8 mRNA expression was assessed using Northern analysis and reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization of lung parenchyma. Compared with normal subjects, IL-8 concentration was significantly greater in both CFA (p < 0.001) and FASSc groups (p < 0.05) but no different in sarcoidosis. The IL-8 concentration in CFA was higher than in FASSc (p < 0.01) and was related to BAL % neutrophils (rs = 0.48, p < 0.01). IL-8 mRNA expression evaluated by Northern analysis was seen only in patients with CFA and FASSc and was related to BAL % neutrophils (rs = 0.63, p < 0.01). We suggest that IL-8 is a key factor in the pathogenesis of fibrosing alveolitis and that the poorer prognosis of CFA compared with FASSc is related to higher levels of IL-8 within the lower respiratory tract.

This article has been cited by other articles:

				M. P. Keane Angiogenesis and Pulmonary Fibrosis: Feast or Famine? Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 207 - 209. [Full Text] [PDF]

				A. Gibejova, F. Mrazek, D. Subrtova, V. Sekerova, J. Szotkowska, V. Kolek, R. M. du Bois, and M. Petrek Expression of Macrophage Inflammatory Protein-3{beta}/CCL19 in Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1695 - 1703. [Abstract] [Full Text] [PDF]

				H Mukae, H Iiboshi, M Nakazato, T Hiratsuka, M Tokojima, K Abe, J Ashitani, J Kadota, S Matsukura, and S Kohno Raised plasma concentrations of {alpha}-defensins in patients with idiopathic pulmonary fibrosis Thorax, July 1, 2002; 57(7): 623 - 628. [Abstract] [Full Text] [PDF]

				J. Behr, B. Degenkolb, F. Krombach, and C. Vogelmeier Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine Eur. Respir. J., May 1, 2002; 19(5): 906 - 911. [Abstract] [Full Text] [PDF]

				C. Lamblin, C. Bergoin, T. Saelens, and B. Wallaert Interstitial lung diseases in collagen vascular diseases Eur. Respir. J., July 1, 2001; 18(32_suppl): 69S - 80s. [Abstract] [Full Text] [PDF]

				N Dauletbaev, J Rickmann, K Viel, R Buhl, T-O-F Wagner, and J Bargon Glutathione in induced sputum of healthy individuals and patients with asthma Thorax, January 1, 2001; 56(1): 13 - 18. [Abstract] [Full Text]

				A. Ludwicka-Bradley, E. Tourkina, S. Suzuki, E. Tyson, M. Bonner, J. W. Fenton II, S. Hoffman, and R. M. Silver Thrombin Upregulates Interleukin-8 in Lung Fibroblasts via Cleavage of Proteolytically Activated Receptor-I and Protein Kinase C-gamma Activation Am. J. Respir. Cell Mol. Biol., February 1, 2000; 22(2): 235 - 243. [Abstract] [Full Text]

				P. Paredi, S. A. Kharitonov, S. Loukides, P. Pantelidis, R. M. d. Bois, and P. J. Barnes Exhaled Nitric Oxide Is Increased in Active Fibrosing Alveolitis Chest, May 1, 1999; 115(5): 1352 - 1356. [Abstract] [Full Text] [PDF]

				S. E. Mutsaers, M. L. Foster, R. C. Chambers, G. J. Laurent, and R. J. McAnulty Increased Endothelin-1 and Its Localization during the Development of Bleomycin-induced Pulmonary Fibrosis in Rats Am. J. Respir. Cell Mol. Biol., May 1, 1998; 18(5): 611 - 619. [Abstract] [Full Text]

				M. W. ZIEGENHAGEN, P. ZABEL, G. ZISSEL, M. SCHLAAK, and J. MULLER-QUERNHEIM Serum Level of Interleukin 8 Is Elevated in Idiopathic Pulmonary Fibrosis and Indicates Disease Activity Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 762 - 768. [Abstract] [Full Text] [PDF]

				S. IMOKAWA, A. SATO, H. HAYAKAWA, M. KOTANI, T. URANO, and A. TAKADA Tissue Factor Expression and Fibrin Deposition in the Lungs of Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 631 - 636. [Abstract] [Full Text]